| Clinical decision making in cancer care: a review of current and future roles of patient age EJ Tranvåg, OF Norheim, T Ottersen BMC cancer 18, 1-7, 2018 | 30 | 2018 |
| Health inequalities in Ethiopia: modeling inequalities in length of life within and between population groups EJ Tranvåg, M Ali, OF Norheim International journal for equity in health 12, 1-8, 2013 | 30 | 2013 |
| Cancer biomarkers: ethics, economics and society A Blanchard, R Strand, JA Cairns, EJ Tranvåg, OF Norheim, MK Seo, ... Megaloceros Press, 2017 | 11 | 2017 |
| Precision medicine and the principle of equal treatment: a conjoint analysis EJ Tranvåg, R Strand, T Ottersen, OF Norheim BMC Medical Ethics 22 (1), 55, 2021 | 10 | 2021 |
| Attitudes towards priority setting in the Norwegian health care system: a general population survey CT Solberg, EJ Tranvåg, M Magelssen BMC health services research 22 (1), 444, 2022 | 7 | 2022 |
| Hvordan påvirker prioriteringsvilkårene rettighetstildelingen i Helsedirektoratets prioriteringsveiledere? EJ Tranvåg, E Nygaard, OF Norheim Michael 12, 416-27, 2015 | 7 | 2015 |
| Appraising drugs based on cost-effectiveness and severity of disease in Norwegian drug coverage decisions EJ Tranvåg, ØA Haaland, B Robberstad, OF Norheim JAMA Network Open 5 (6), e2219503-e2219503, 2022 | 4 | 2022 |
| Confidential drug prices undermine trust in the system EJ Tranvåg Tidsskrift for Den norske legeforening, 2019 | 4 | 2019 |
| How can boimarkers influence priority setting for cancer drugs EJ Tranvåg, OF Norheim Cancer biomarkers: ethics, economics and society. 2nd ed. Kokstand …, 2017 | 3 | 2017 |
| Organdonasjon med bruk av normoterm regional perfusjon hos pasienter som dør av hjerte-og åndedrettsstans når livsforlengende behandling avsluttes L Giske, B Solberg, EJ Tranvåg, J Dahlberg, M Halvorsen, EV Hafstad, ... Folkehelseinstituttet, område for helsetjenester, 2018 | 2 | 2018 |
| Ebola er ikke Sierra Leones største problem EJ Tranvåg, KH Onarheim Tidsskrift for Den norske legeforening, 2015 | 2 | 2015 |
| Rationing of Personalised Cancer Drugs: Rethinking the Co-production of Evidence and Priority Setting Practices EJ Tranvåg, R Strand Precision Oncology and Cancer Biomarkers: Issues at Stake and Matters of …, 2022 | | 2022 |
| Precision and Uncertainty: Cancer biomarkers and new perspectives on fairness in priority setting decisions in personalized medicine EJ Tranvåg The University of Bergen, 2021 | | 2021 |
| Precision medicine and the principle of equal treatment: a conjoint analysis OF Norheim, T Ottersen, R Strand, EJ Tranvåg | | 2021 |
| Kritikk av ondartet kreftpolitikk EJ Tranvåg Tidsskrift for Den norske legeforening, 2020 | | 2020 |
| Konfidensielle legemiddelpriser undergraver tilliten til systemet EJ Tranvåg Tidsskrift for Den norske legeforening, 2019 | | 2019 |
| Is proton therapy the correct use of scarce resources? EJ Tranvåg Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny …, 2018 | | 2018 |
| Er protonterapi riktig bruk av sparsomme ressurser? EJ Tranvåg Tidsskrift for Den norske legeforening, 2018 | | 2018 |
| EJ Tranvåg & KH Onarheim svarer EJ Tranvåg, KH Onarheim Tidsskrift for Den norske legeforening, 2016 | | 2016 |
| Ebola is not Sierra Leone's biggest problem EJ Tranvåg, KH Onarheim Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin, ny …, 2015 | | 2015 |
Ole F. NorheimUniversity of Bergen and Harvard TH Chan School of Public Health在 uib.no 的电子邮件经过验证
